tiprankstipranks
Advertisement
Advertisement
Psychedelic: Clearmind reports results from first cohort in AUD trial
PremiumThe FlyPsychedelic: Clearmind reports results from first cohort in AUD trial
4M ago
Silo Pharma partners with Allucent for planned FDA IND application for SPC-15
Premium
The Fly
Silo Pharma partners with Allucent for planned FDA IND application for SPC-15
4M ago
Silo Pharma selects AlphaLedger’s T12 Fund for tokenized RWA investments
Premium
The Fly
Silo Pharma selects AlphaLedger’s T12 Fund for tokenized RWA investments
5M ago
Silo Pharma announces initial Bitcoin purchase
PremiumThe FlySilo Pharma announces initial Bitcoin purchase
6M ago
Silo Pharma acquires ResearchCoin crypto tokens
Premium
The Fly
Silo Pharma acquires ResearchCoin crypto tokens
6M ago
Silo Pharma Secures $2.5M in Stock Sale Agreement
Premium
Company Announcements
Silo Pharma Secures $2.5M in Stock Sale Agreement
6M ago
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
PremiumThe FlyPsychedelic: Cybin completes enrollment in CYB004 Phase 2 study
6M ago
Silo Pharma announces Japanese patent for PTSD drug
Premium
The Fly
Silo Pharma announces Japanese patent for PTSD drug
7M ago
Psychedelic: Bright Minds reports preclinical BMB-201 results
Premium
The Fly
Psychedelic: Bright Minds reports preclinical BMB-201 results
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100